Literature DB >> 33950586

[COVID-19 Diagnosis].

Jean-Marc Schwob1, Alix Miauton1, Maxime Hostettler1, Julien Thabard1, Blaise Genton1, Valérie D'acremont1.   

Abstract

The need to curb the circulation of SARS-CoV-2 virus in the community and to diagnose those at risk of developing complications implies that an appropriate test should be chosen according to the epidemiological and clinical context. Rapid antigen tests, either nasopharyngeal or nasal, have the advantage of reflecting contagiousness better than PCR and giving an immediate result, reason why they are used as first-line for community diagnosis and screening. A rapid test allows immediate management of outpatients and does not falsely attribute the current acute episode to a previous SARS-CoV-2 infection. PCR, whether nasopharyngeal or buccosalivary, is useful for epidemiological surveillance, including that of new variants, as well as identification of severe COVID in the post-infectious phase.

Entities:  

Mesh:

Year:  2021        PMID: 33950586

Source DB:  PubMed          Journal:  Rev Med Suisse        ISSN: 1660-9379


  2 in total

1.  Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors.

Authors:  Lukas E Brümmer; Stephan Katzenschlager; Sean McGrath; Stephani Schmitz; Mary Gaeddert; Christian Erdmann; Marc Bota; Maurizio Grilli; Jan Larmann; Markus A Weigand; Nira R Pollock; Aurélien Macé; Berra Erkosar; Sergio Carmona; Jilian A Sacks; Stefano Ongarello; Claudia M Denkinger
Journal:  PLoS Med       Date:  2022-05-26       Impact factor: 11.613

2.  Contribution of COVID Antigenic RDT to the Management Strategy of COVID-19 Pandemic in a Senegalese Company.

Authors:  Asséga Sylvain Sagna; Aïssatou Goundo Seydi; Modou Mbacké Gueye; Mame Thioro Aïssatou Fall; Jean Michel Mansuy
Journal:  J Occup Environ Med       Date:  2022-01-25       Impact factor: 2.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.